DOTmed April 19, 2024
Engaging diverse patient populations is essential to clinical research for many reasons, including:
● Disease epidemiology. We know there are biological differences in how various diseases impact different individuals. If we’re not reaching those populations that could benefit the most from the medicines, vaccines and/or devices being researched, we’re doing a disservice to those communities.
● Safety and efficacy data. It is important to assess the effect of potential therapies and devices within a controlled research environment. Failing to reflect diverse populations in clinical trial data may prevent their safe roll-out and limit their efficacy within specific populations.
Still, efforts to increase diversity, equity, and inclusion (DEI) in clinical trials often encounter barriers. In many cases, this is because of...
Today's Sponsors
Today's Sponsor